carvedilol and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

carvedilol has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jabbal, S; Lipworth, BJ	1

Other Studies

1 other study(ies) available for carvedilol and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

Article	Year
Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD. Lung, 2018, Volume: 196, Issue:1 Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Aged; Airway Resistance; Anti-Inflammatory Agents; Beclomethasone; Bronchoconstriction; Carvedilol; Forced Expiratory Volume; Formoterol Fumarate; Humans; Lung Compliance; Oscillometry; Pulmonary Disease, Chronic Obstructive	2018

Article

Year

Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD.

Lung, 2018, Volume: 196, Issue:1

Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Aged; Airway Resistance; Anti-Inflammatory Agents; Beclomethasone; Bronchoconstriction; Carvedilol; Forced Expiratory Volume; Formoterol Fumarate; Humans; Lung Compliance; Oscillometry; Pulmonary Disease, Chronic Obstructive

2018